These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Prediction of tumor absorbed dose by Tc-99m-MDP scintigraphy prior to treatment with Sr-89. Manetou A; Limourls GS Anticancer Res; 1997; 17(3B):1845-7. PubMed ID: 9179243 [TBL] [Abstract][Full Text] [Related]
23. Visualization of metastatic liver disease on technetium-99m bone scintigraphy. Romyn AM; Bushnell DL; Freeman ML; Kaplan E Clin Nucl Med; 1987 Apr; 12(4):264-7. PubMed ID: 3581604 [TBL] [Abstract][Full Text] [Related]
24. Diffuse liver uptake on (99m)Tc-MDP bone scan secondary to severe hepatic failure. Chen P; Marentis T; Brown RK Clin Nucl Med; 2014 Jul; 39(7):658-9. PubMed ID: 24873795 [TBL] [Abstract][Full Text] [Related]
25. Bilateral lung 99mTc-MDP uptake on the bone scintigraphy in the myelodysplastic syndromes (MDS). Mogharrabi M; Javadi H; Assadi M Clin Nucl Med; 2013 May; 38(5):372-4. PubMed ID: 23531771 [TBL] [Abstract][Full Text] [Related]
26. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP. Wulfrank DA; Schelstraete KH; Small F; Fallais CJ Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315 [TBL] [Abstract][Full Text] [Related]
27. 99mTc-MDP uptake and histological changes during rat bone marrow regeneration. Chisin R; Gazit D; Ulmansky M; Laron A; Atlan H; Sela J Int J Rad Appl Instrum B; 1988; 15(4):469-76. PubMed ID: 3255743 [TBL] [Abstract][Full Text] [Related]
29. Panostotic fibrous dysplasia. A new craniotubular dysplasia. Leslie WD; Reinhold C; Rosenthall L; Tau C; Glorieux FH Clin Nucl Med; 1992 Jul; 17(7):556-60. PubMed ID: 1638836 [TBL] [Abstract][Full Text] [Related]
30. Gallbladder visualization on a technetium-99m MDP bone scan. Lisann NM; Palestro CJ; Novich IS; Benua RS Clin Nucl Med; 1986 Jan; 11(1):57-8. PubMed ID: 3943247 [TBL] [Abstract][Full Text] [Related]
31. Tc-99m MDP bone imaging in inflammatory enthesopathy. Aburano T; Yokoyama K; Taki J; Nakajima K; Tonami N; Hisada K Clin Nucl Med; 1990 Feb; 15(2):105-6. PubMed ID: 2311317 [TBL] [Abstract][Full Text] [Related]
32. Ivory vertebra appearing photopenic on Tc-99m MDP bone scan: demonstration by SPECT/CT. Aide N; Costo S; Lheureux S; Allouache N; Bardet S Clin Nucl Med; 2008 Jul; 33(7):479-81. PubMed ID: 18580234 [TBL] [Abstract][Full Text] [Related]
33. Soft tissue uptake on Tc-99m MDP bone scan after cardioversion. Vanhecke W; Merckx E; De Roo M; Mortelmans L Clin Nucl Med; 1989 Dec; 14(12):923. PubMed ID: 2605853 [No Abstract] [Full Text] [Related]
34. Bone scan of advanced polycythemia vera with malignant transformation. Seymour PC; Line BR Clin Nucl Med; 1996 Nov; 21(11):844-6. PubMed ID: 8922844 [TBL] [Abstract][Full Text] [Related]
35. Leuprolide therapy for prostate cancer. An association with scintigraphic "flare" on bone scan. Johns WD; Garnick MB; Kaplan WD Clin Nucl Med; 1990 Jul; 15(7):485-7. PubMed ID: 2116949 [TBL] [Abstract][Full Text] [Related]
36. Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy. Hommeyer SH; Varney DM; Eary JF J Nucl Med; 1992 May; 33(5):748-50. PubMed ID: 1569485 [TBL] [Abstract][Full Text] [Related]
37. Can bone scans detect ureteral obstruction due to carcinoma of the prostate? Horan AH; Smith L; Farringer B; Seddon JM Indiana Med; 1987 Jul; 80(7):642-4. PubMed ID: 3611731 [No Abstract] [Full Text] [Related]
39. Bone marrow scan using Tc-99m-labeled anti-granulocyte antibody to evaluate hematopoiesis in osteomyelofibrosis. GrĂ¼ning T; Franke WG Clin Nucl Med; 2000 Mar; 25(3):222-3. PubMed ID: 10698429 [No Abstract] [Full Text] [Related]
40. A case of a gigantic urine bladder due to prostate cancer obstruction on a technetium-99m methyl diphosphonate bone scan. Erkan ME; Ilce HT; Korkmaz N; Buyukkaya R; Yildirim M Hell J Nucl Med; 2007; 10(2):120. PubMed ID: 17684591 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]